Ontology highlight
ABSTRACT: Patient summary
For men with testicular cancer, levels of tumor markers in their blood are used when making decisions on chemotherapy intensity. Use of test results for samples taken before removal of the cancer-bearing testicle instead of immediately before chemotherapy can lead to inadequate treatment recommendations.
SUBMITTER: Fankhauser CD
PROVIDER: S-EPMC10497784 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
Fankhauser Christian D CD Jandari Abolghassem A Collette Laurence L Tandstad Torgrim T Jiang Di Maria DM De Giorgi Ugo U Sweeney Christopher C Terbuch Angelika A Chovanec Michal M Huddart Robert R Bokemeyer Carsten C Beyer Jörg J Gillessen Silke S
European urology open science 20230909
Levels of the serum tumor markers (STMs) α-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase are used in staging classification for metastatic germ-cell cancers and support decisions on the intensity of first-line treatment for patients with nonseminoma. Use of preorchiectomy instead of prechemotherapy STM levels can lead to inadequate classification. We identified 744 men with metastatic gonadal nonseminoma in the International Germ-Cell Cancer Collaborative Group (IGCCCG) Up ...[more]